NURECA
Back to All Ratios
|
NURECA Last 5 Year Net Sales Growth History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales Growth(%) | -17.42 | -56.44 | 19.72 | 114.69 | 60.63 |
What is the latest Net Sales Growth ratio of NURECA ?
Year | Net Sales Growth |
---|---|
Mar2024 | -17.42 |
Mar2023 | -56.44 |
Mar2022 | 19.72 |
Mar2021 | 114.69 |
Mar2020 | 60.63 |
How is Net Sales Growth of NURECA Trending?
Years | Net Sales Growth | % Change | |
---|---|---|---|
Mar2024 | -17.42 | Negative | |
Mar2023 | -56.44 | Negative | |
Mar2022 | 19.72 | -82.81 | |
Mar2021 | 114.69 | 89.16 | |
Mar2020 | 60.63 | - |
Other Financial Ratios of NURECA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Net Sales Growth ratio of peers of NURECA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NURECA | ₹281.1 Cr | -2.5% | 2.5% | -22.9% | Stock Analytics | |
POLY MEDICURE | ₹26,321.9 Cr | -8.9% | 0.3% | 74.6% | Stock Analytics | |
PREVEST DENPRO | ₹686.9 Cr | -5.5% | 5.9% | 37.7% | Stock Analytics |
NURECA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NURECA | -2.5% |
2.5% |
-22.9% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses